Healthware has launched a new online resource that aggregates information and analysis on how to respond to the huge changes COVID-19 has wrought across life sciences and healthcare.
The open access newnormal.health aims to help guide executives from pharma, biotech and medical device companies in their response to the pandemic and its aftermath.
Roberto Ascione, Healthware Group’s CEO, said:
The ‘new normal’ is a seismic shift for the life sciences industry and requires a transformation of how we conceive of healthcare that’s far broader than just an app or other piece of technology. We need to be thinking about how people, processes and policies need to change.
The site contains content from Healthware and its partners, including pharmaphorum, and covers customer engagement, digital health, digital transformation, and trends and perspectives on future scenarios for the industry.